- Primary objective: evaluate and compare safety of the [[FDC]] against [[albendazole]] alone via [[MDA]] in two study areas in [[Kenya]] and [[Ghana]]
- Secondary objectives:
- Evaluate the effectiveness of one round of MDA with FDC vs albendazole against STH by microscopy
- Evaluate the effectiveness of one round of [[MDA]] with [[FDC]] vs [[albendazole]] against [[STH]] by microscopy
- Evaluate the effectiveness of one round of [[MDA]] with [[FDC]] vs [[albendazole]] against [[Strongyloides stercolaris]] by serology
- Primary goal: Safety (incidence of SAEs)
- Secondary goals: Effectiveness at
- Nuestros objetivos:
- Overall goal: Support the achievement of the [[WHO]] 2030 NTD Roadmap for [[STH]] and beyond
- Project purpose: Advance and accelerate an innovative pharmacological tool to support the elimination goals against [[STH]] species, especially those poorly responsive to current treatment regimens
Borja Robert
11 months ago